Lancaster Resources Inc.

Lancaster Resources Inc.

LCR.CN
Lancaster Resources Inc.CA flagCanadian Securities Exchange
0.02
CAD
- -
- -
1.19MMarket Cap
Lancaster Resources Inc.
LCR.CN
(Canadian Securities Exchange)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-2.86
-7.33
-1.8
-0.15
-0.08
-0.03
-0.02
Basic EPS, GAAP
- -
-0.91
-5.92
-0.96
-0.04
-0.03
- -
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-4.38
-5.38
-5.96
-0.02
-0.06
-0.07
-0.04
Book Value per Share
- -
-0.86
0.3
-1.24
0.05
-0.01
-0.03
-0.01
Tangible Book Value per Share
- -
1
1
1
20
45
56
86
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-3
-7
-2
-3
-4
-2
-2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1
- -
1
-1
1
-1
-2
- -
Working Capital
- -
1
- -
1
- -
- -
- -
1
LT Debt
-1
-1
- -
-1
1
-1
-2
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'26
Sep'26
Dec'26
ST Debt
- -
- -
- -
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
91
92
108
Market Capitalization
3
3
5

Working Capital

FRC

in mil. unless spec.
Jun'26
Sep'26
Dec'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-168.51%
211.04%
Free Cash Flow
- -
90.42%
-92.87%
Net Income, GAAP
- -
21.76%
-57.46%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.07
-0.01
-0.01
-0.08
2025
-0.01
-0.01
- -
- -
-0.03
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Lancaster Resources Inc. (CSE: LCR, OTC: LANRF, FRA: 6UF0) explores and develops gold, polymetallic, uranium, and lithium properties in Canada, Australia, and the United States. The company holds a 100% interest in the district-scale Lake Cargelligo Gold Project covering 62,300 hectares in New South Wales, Australia; the Lac Iris Polymetallic Project spanning approximately 1,870 hectares in Quebec's James Bay region; the Piney Lake Gold Project in Saskatchewan; uranium projects at Catley Lake and Centennial East in Saskatchewan's Athabasca Basin; and an option to acquire the Trans-Taiga Lithium Project in Quebec's James Bay area. Lancaster Resources maintains headquarters in Vancouver, British Columbia, Canada, and was founded in 2019. Lancaster Resources operates within the critical minerals and precious metals exploration sector, targeting high-potential assets in established mining jurisdictions to support energy transition and value creation. Recent developments include the completion of the acquisition of the Lac Iris Polymetallic Project in August 2025; the doubling of the Lake Cargelligo Gold Project footprint to 62,300 hectares in September 2025; the appointment of veteran explorer Ross Brown as Vice President, Exploration in September 2025 to lead the Lake Cargelligo project; the release of positive rock assay results from Lake Cargelligo in September 2025; and the completion of its maiden NI 43-101 technical report for Lake Cargelligo in October 2025.